Medtronic plc (MDT)
NYSE: MDT · Real-Time Price · USD
96.54
-0.57 (-0.59%)
At close: Oct 30, 2026, 4:00 PM EDT
96.65
+0.11 (0.11%)
After-hours: Oct 30, 2026, 7:59 PM EDT
Medtronic Revenue
Medtronic had revenue of $9.76B in the quarter ending July 31, 2026, with 13.73% growth. This brings the company's total for the last twelve months to $37.54B, up 9.77% year-over-year. In the fiscal year ending April 24, 2026, Medtronic had annual revenue of $36.36B with 8.43% growth. That makes Medtronic the 368th largest company in the world by revenue and 131st in the United States.
Revenue (ttm)
$37.54B
Revenue Growth
+9.77%
P/S Ratio
3.15
Revenue / Employee
$395,179
Employees
95,000
Market Cap
118.18B
Revenue by Segment
Fiscal year ended Apr 25, 2025 See the full Medtronic breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 24, 2026 | 36.36B | 2.83B | 8.43% |
| Apr 25, 2025 | 33.54B | 1.17B | 3.62% |
| Apr 26, 2024 | 32.36B | 1.14B | 3.64% |
| Apr 28, 2023 | 31.23B | -459.00M | -1.45% |
| Apr 29, 2022 | 31.69B | 1.57B | 5.21% |
| Apr 30, 2021 | 30.12B | 1.20B | 4.16% |
| Apr 24, 2020 | 28.91B | -1.64B | -5.38% |
| Apr 26, 2019 | 30.56B | 604.00M | 2.02% |
| Apr 27, 2018 | 29.95B | 243.00M | 0.82% |
| Apr 28, 2017 | 29.71B | 877.00M | 3.04% |
| Apr 29, 2016 | 28.83B | 8.57B | 42.31% |
| Apr 24, 2015 | 20.26B | 3.26B | 19.15% |
| Apr 25, 2014 | 17.01B | 415.00M | 2.50% |
| Apr 26, 2013 | 16.59B | 406.00M | 2.51% |
| Apr 27, 2012 | 16.18B | 676.00M | 4.36% |
| Apr 29, 2011 | 15.51B | 116.00M | 0.75% |
| Apr 30, 2010 | 15.39B | 793.00M | 5.43% |
| Apr 24, 2009 | 14.60B | 1.08B | 8.02% |
| Apr 25, 2008 | 13.52B | 1.22B | 9.89% |
| Apr 27, 2007 | 12.30B | 1.01B | 8.92% |
| Apr 28, 2006 | 11.29B | 1.24B | 12.30% |
| Apr 29, 2005 | 10.06B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Abbott Laboratories | 48.23B |
| Stryker | 26.30B |
| GE HealthCare Technologies | 21.64B |
| Boston Scientific | 21.07B |
| Koninklijke Philips | 20.18B |
| Zimmer Biomet Holdings | 8.51B |
| Edwards Lifesciences | 6.51B |
| STERIS | 6.04B |
MDT News
- 2 days ago - Orchestra BioMed Announces Virtue SAB Presentation at TCT 2026 - GlobeNewsWire
- 9 days ago - Orchestra BioMed to Host R&D Day Featuring Clinical Insights and Development Plans for AVIM Therapy and Virtue® SAB - GlobeNewsWire
- 9 days ago - Medtronic reports results from Sphere-9 catheter, PulseSelect PFA System - TheFly
- 9 days ago - Medtronic announces positive results from real-world registries for the Sphere-9™ catheter and PulseSelect™ PFA System at APHRS 2026 - PRNewsWire
- 15 days ago - Medtronic EVP, Pres MedSurg and Americas Marinaro Michael sells $1M of shares - TheFly
- 15 days ago - Medtronic Chairman and CEO sells $4.75M of company shares - TheFly
- 16 days ago - Medtronic Named to TIME Best Inventions of 2026 List for Stealth AXiS™ surgical system and Corsano™* multi-parameter wearable - PRNewsWire
- 16 days ago - Medtronic Completes Separation of MiniMed Group, Inc. - PRNewsWire